calina-d 1
1. The role of Tumour Necrosis Factor in neuroinflammation associated with Parkinsons disease and targeted therapies
2. Global, regional, and national progress towards the 2030 global nutrition targets and forecasts to 2050: a systematic analysis for the Global Burden of Disease Study 2021
3. Potential mechanisms of quercetin in cancer prevention: focus on cellular and molecular targets
4. Ferroptosis in Cholangiocarcinoma Therapy: Molecular Mechanisms, Pharmacological Modulation and Opportunities for Drug Development
5. Current Evidence on Molecular Mechanisms of Andrographolide in Cancer
6. Global fertility in 204 countries and territories, 1950–2021, with forecasts to 2100: a comprehensive demographic analysis for the Global Burden of Disease Study 2021
7. Global burden and strength of evidence for 88 risk factors in 204 countries and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021
8. Forecasting the effects of smoking prevalence scenarios on years of life lost and life expectancy from 2022 to 2050: a systematic analysis for the Global Burden of Disease Study 2021
9. Casticin as potential anticancer agent: recent advancements in multi-mechanistic approaches
10. Camellia sinensis: Insights on its molecular mechanisms of action towards nutraceutical, anticancer potential and other therapeutic applications
11. Oxidative stress, free radicals and antioxidants: potential crosstalk in the pathophysiology of human diseases
12. Sesquiterpenoid lactones as potential anti-cancer agents: an update on molecular mechanisms and recent studies
13. Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in 204 countries and territories and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021
14. Prevalence, years lived with disability, and trends in anaemia burden by severity and cause, 1990–2021: findings from the Global Burden of Disease Study 2021
15. Natural essential oils as a new therapeutic tool in colorectal cancer
16. Burden of 375 diseases and injuries, risk-attributable burden of 88 risk factors, and healthy life expectancy in 204 countries and territories, including 660 subnational locations, 1990–2023: a systematic analysis for the Global Burden of Disease Study 2023
17. Biosynthesis of Secondary Metabolites Based on the Regulation of MicroRNAs
18. Lasia spinosa Chemical Composition and Therapeutic Potential: A Literature-Based Review
19. Natural Compounds or Their Derivatives against Breast Cancer: A Computational Study
20. The global, regional, and national burden attributable to low bone mineral density, 1990–2020: an analysis of a modifiable risk factor from the Global Burden of Disease Study 2021
21. Current stage of preclinical and clinical development of guggulsterone in cancers: Challenges and promises
22. Rosmarinic acid and its derivatives: Current insights on anticancer potential and other biomedical applications
23. Rosmarinic acid and its derivatives: Current insights on anticancer potential and other biomedical applications
24. An updated overview of anticancer effects of alternariol and its derivatives: underlying molecular mechanisms
25. Neuropharmacological Effects of Quercetin: A Literature-Based Review
26. Therapeutic strategies for rheumatic diseases and disorders: targeting redox imbalance and oxidative stress
27. Global burden of amphetamine, cannabis, cocaine and opioid use in 204 countries, 1990–2023: a Global Burden of Disease Study
28. Global, regional, and national prevalence of child and adolescent overweight and obesity, 1990–2021, with forecasts to 2050: a forecasting study for the Global Burden of Disease Study 2021
29. Global, regional and national burden of dietary iron deficiency from 1990 to 2021: a Global Burden of Disease study
30. Nutritional Sources and Anticancer Potential of Phenethyl Isothiocyanate: Molecular Mechanisms and Therapeutic Insights
31. Rumex Species: Phytochemistry, Pharmacology and Nutritional Potential for Food and Health Applications
32. Global burden of chronic respiratory diseases and risk factors, 1990–2019: an update from the Global Burden of Disease Study 2019
33. Global burden of 288 causes of death and life expectancy decomposition in 204 countries and territories and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021
34. Updated aspects of alpha-Solanine as a potential anticancer agent: Mechanistic insights and future directions
35. Global, regional, and national prevalence of adult overweight and obesity, 1990–2021, with forecasts to 2050: a forecasting study for the Global Burden of Disease Study 2021
36. Global, regional, and national burden of chronic respiratory diseases and impact of the COVID-19 pandemic, 1990–2023: a Global Burden of Disease study
37. Global, regional, and national burden of diabetes from 1990 to 2021, with projections of prevalence to 2050: a systematic analysis for the Global Burden of Disease Study 2021
38. Nutraceutical Profiling, Bioactive Composition, and Biological Applications of Lepidium sativum L.
39. Anticancer properties of bromelain: State-of-the-art and recent trends
40. Phytates as a natural source for health promotion: A critical evaluation of clinical trials
41. Medicinal and mechanistic overview of artemisinin in the treatment of human diseases
42. Honokiol and its analogues as anticancer compounds: Current mechanistic insights and structure-activity relationship
43. Pharmacological Properties of Bergapten: Mechanistic and Therapeutic Aspects
44. An updated pharmacological insight into calotropin as a potential therapeutic agent in cancer
45. Global, Regional, and National Burden of Nontraumatic Subarachnoid Hemorrhage The Global Burden of Disease Study 2021
46. Ficus plants: State of the art from a phytochemical, pharmacological, and toxicological perspective
47. Global age-sex-specific mortality, life expectancy, and population estimates in 204 countries and territories and 811 subnational locations, 1950–2021, and the impact of the COVID-19 pandemic: a comprehensive demographic analysis for the Global Burden of Disease Study 2021
48. Artemisia spp.: An Update on Its Chemical Composition, Pharmacological and Toxicological Profiles
49. Bioactive compounds from Prosopis species as potential oxidative stress and inflammation modulators: an update on mechanisms
50. Multi-Target Mechanisms of Phytochemicals in Alzheimer’s Disease: Effects on Oxidative Stress, Neuroinflammation and Protein Aggregation
1 2